Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision
NEW YORK, December 11, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts' Corner announced new research reports highlighting AbbVie Inc. (NYSE: ABBV), Covance Inc. (NYSE: CVD), MannKind Corp. (NASDAQ: MNKD), MAKO Surgical Corp. (NASDAQ: MAKO), and Envision Healthcare Holdings, Inc. (NYSE: EVHC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
AbbVie Inc. Research Report
On December 6, 2013, AbbVie Inc.'s (AbbVie) stock increased 3.20%, ending the day's session at $51.35. Over the previous three trading sessions, shares of AbbVie increased 2.76%, compared to the Dow Jones Industrial Average Index which increased 0.66% during the same period. The Full Research Report on AbbVie Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.AnalystsCorner.com/r/full_research_report/273c_ABBV
Covance Inc. Research Report
On December 6, 2013, Covance Inc.'s (Covance) stock increased 2.01%, ending the day's session at $86.82. Over the previous three trading sessions, shares of Covance increased 3.95%, compared to the Dow Jones Industrial Average Index which increased 0.66% during the same period. The Full Research Report on Covance Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.AnalystsCorner.com/r/full_research_report/5691_CVD
MannKind Corp. Research Report
On December 6, 2013, MannKind Corp.'s (MannKind) stock increased 3.02%, ending the day's session at $5.12. Over the previous three trading sessions, shares of MannKind increased 2.20%, compared to the Dow Jones Industrial Average Index which increased 0.66% during the same period. The Full Research Report on MannKind Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.AnalystsCorner.com/r/full_research_report/044e_MNKD
MAKO Surgical Corp. Research Report
On December 6, 2013, MAKO Surgical Corp.'s (MAKO Surgical) stock ended the day's session flat at $29.97. Over the previous three trading sessions, shares of MAKO Surgical increased 0.10%, compared to the Nasdaq Composite Index which increased 0.63% during the same period. The Full Research Report on MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.AnalystsCorner.com/r/full_research_report/7465_MAKO
Envision Healthcare Holdings, Inc. Research Report
On December 6, 2013, Envision Healthcare Holdings, Inc.'s (Envision) stock increased 2.21%, ending the day's session at $30.99. Over the previous three trading sessions, shares of Envision increased 5.88%, compared to the Dow Jones Industrial Average Index which increased 0.66% during the same period. The Full Research Report on Envision Healthcare Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:
http://www.AnalystsCorner.com/r/full_research_report/4b31_EVHC
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to making mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.AnalystsCorner.com/
SOURCE Analysts' Corner
Share this article